HemaSphere (Jun 2022)

S187: UPDATED PHASE 1/2 DATA OF SAFETY AND EFFICACY OF CT103A, FULLY HUMAN BCMA-DIRECTED CAR T CELLS, IN RELAPSED/REFRACTORY MULTIPLE MYELOMA

  • C. Li,
  • D. Wang,
  • Y. Song,
  • J. Li,
  • H Huang,
  • B. Chen,
  • J. Liu,
  • K. Hu,
  • H. Ren,
  • X. Zhang,
  • Z. Li,
  • D. Zou,
  • Q. Yin,
  • L. Chen,
  • Y. Hu,
  • Y. Xu,
  • Q. Cheng,
  • Y. Guo,
  • Y. Dong,
  • L. Gao,
  • S. Chen,
  • A. Xu,
  • S. Cai,
  • M. Wu,
  • J. Guo,
  • Z. Yao,
  • W. Wang,
  • J. Wang,
  • L. Chen,
  • J. Zhou,
  • L. Qiu

DOI
https://doi.org/10.1097/01.HS9.0000843640.50080.cc
Journal volume & issue
Vol. 6
pp. 88 – 89

Abstract

Read online

No abstracts available.